Skip to content

ESLA

Estrella Immunopharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.41
−1.36%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
0.18x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
-2.41x
Price / sales
—
Price / cash flow
-1.91x

Enterprise value

Enterprise value
$17.8M
EV / sales
—
EV / EBITDA
-1.82x
EV / EBIT
-1.82x
Market cap
$17.9M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026